These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 1220835)
1. Acceptability of the cytopipette in screening for cervical cancer. Carruthers J; Wilson JM; Chamberlain J; Husain OA; Patey DG; Richards ND; Pennicott A; Rogers P; Catling R; Meade TW; Saunders J; McEwan PJ Br J Prev Soc Med; 1975 Dec; 29(4):239-48. PubMed ID: 1220835 [TBL] [Abstract][Full Text] [Related]
2. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009]. Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201 [TBL] [Abstract][Full Text] [Related]
3. Cervical screening in general practice: call and recall. Ridsdale LL J R Coll Gen Pract; 1987 Jun; 37(299):257-9. PubMed ID: 3129556 [TBL] [Abstract][Full Text] [Related]
4. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland]. Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397 [TBL] [Abstract][Full Text] [Related]
5. Investigation of non-responders at a cervical cancer screening clinic in Manchester. Nathoo V Br Med J (Clin Res Ed); 1988 Apr; 296(6628):1041-2. PubMed ID: 3130132 [TBL] [Abstract][Full Text] [Related]
6. [Participation in the Dutch national screening programme for uterine cervic cancer higher after invitation by a general practitioner, especially in groups with a traditional low level of attendance]. de Nooijer DP; de Waart FG; van Leeuwen AW; Spijker WW Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2339-43. PubMed ID: 16261714 [TBL] [Abstract][Full Text] [Related]
7. Acceptability of self-collected vaginal samples for HPV testing in an urban and rural population of Madagascar. Broquet C; Triboullier D; Untiet S; Schafer S; Petignat P; Vassilakos P Afr Health Sci; 2015 Sep; 15(3):755-61. PubMed ID: 26957962 [TBL] [Abstract][Full Text] [Related]
8. Attitudes to self-sampling of vaginal smear for human papilloma virus analysis among women not attending organized cytological screening. Wikström I; Stenvall H; Wilander E Acta Obstet Gynecol Scand; 2007; 86(6):720-5. PubMed ID: 17520406 [TBL] [Abstract][Full Text] [Related]
9. Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women. Bosgraaf RP; Ketelaars PJ; Verhoef VM; Massuger LF; Meijer CJ; Melchers WJ; Bekkers RL Prev Med; 2014 Jul; 64():108-13. PubMed ID: 24736093 [TBL] [Abstract][Full Text] [Related]
10. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia. Brotherton JM; Mullins RM Cancer Epidemiol; 2012 Jun; 36(3):298-302. PubMed ID: 22204834 [TBL] [Abstract][Full Text] [Related]
11. Prospective study of predictors of attendance for breast screening in inner London. Sutton S; Bickler G; Sancho-Aldridge J; Saidi G J Epidemiol Community Health; 1994 Feb; 48(1):65-73. PubMed ID: 8138773 [TBL] [Abstract][Full Text] [Related]
12. How can young women be encouraged to attend cervical cancer screening? Suggestions from face-to-face and internet focus group discussions with 30-year-old women in Stockholm, Sweden. Blomberg K; Tishelman C; Ternestedt BM; Törnberg S; Levál A; Widmark C Acta Oncol; 2011 Jan; 50(1):112-20. PubMed ID: 21091087 [TBL] [Abstract][Full Text] [Related]
13. Attitudes toward self-sampling for cervical cancer screening among primary care attendees living on the US-Mexico border. Penaranda E; Molokwu J; Hernandez I; Salaiz R; Nguyen N; Byrd T; Shokar N South Med J; 2014 Jul; 107(7):426-32. PubMed ID: 25010584 [TBL] [Abstract][Full Text] [Related]
14. Acceptability of the cytopipette in a general hospital. Lucas AJ; Attwood ME Br Med J; 1970 May; 2(5705):358-9. PubMed ID: 5429462 [TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program. Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715 [TBL] [Abstract][Full Text] [Related]
16. Screening for breast and cervical cancer in a large German city: participation, motivation and knowledge of risk factors. Klug SJ; Hetzer M; Blettner M Eur J Public Health; 2005 Feb; 15(1):70-7. PubMed ID: 15788807 [TBL] [Abstract][Full Text] [Related]
17. How do women who choose not to participate in population-based cervical cancer screening reason about their decision? Blomberg K; Ternestedt BM; Törnberg S; Tishelman C Psychooncology; 2008 Jun; 17(6):561-9. PubMed ID: 17886262 [TBL] [Abstract][Full Text] [Related]
18. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. Nygård JF; Skare GB; Thoresen SØ J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929 [TBL] [Abstract][Full Text] [Related]
19. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing. Racey CS; Gesink DC J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118 [TBL] [Abstract][Full Text] [Related]
20. Acceptability of unsupervised HPV self-sampling using written instructions. Waller J; McCaffery K; Forrest S; Szarewski A; Cadman L; Austin J; Wardle J J Med Screen; 2006; 13(4):208-13. PubMed ID: 17217611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]